Tykhe Corp Stock Today

HALB Stock  USD 0  0.0003  8.33%   

Performance

0 of 100

 
Weak
 
Strong
Very Weak

Odds Of Distress

Less than 27

 
High
 
Low
Below Average
Tykhe Corp is trading at 0.0039 as of the 1st of December 2024, a 8.33% increase since the beginning of the trading day. The stock's open price was 0.0036. Tykhe Corp has about a 27 % chance of experiencing some form of financial distress in the next two years of operation but has generated negative returns over the last 90 days. Equity ratings for Tykhe Corp are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 7th of December 2023 and ending today, the 1st of December 2024. Click here to learn more.
Halberd Corporation, a biotech company, develops treatments for neurodegenerative diseases. The company was incorporated in 2009 and is based in Jackson Center, Pennsylvania. HALBERD CORP is traded on OTC Exchange in the United States. More on Tykhe Corp

Moving together with Tykhe Pink Sheet

  0.9NVO Novo Nordisk ASPairCorr
  0.89NONOF Novo Nordisk ASPairCorr
  0.76CSLLY CSLPairCorr
  0.65CMXHF CSL LimitedPairCorr
  0.87REGN Regeneron PharmaceuticalsPairCorr

Moving against Tykhe Pink Sheet

  0.84BMA Banco Macro SAPairCorr
  0.82PLTR Palantir Technologies Aggressive PushPairCorr
  0.64KAKZF Kaspi Bank JointPairCorr
  0.61KB KB Financial GroupPairCorr
  0.44AMKBY AP Moeller MaerskPairCorr
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

Tykhe Pink Sheet Highlights

Business ConcentrationBiotechnology, Healthcare (View all Sectors)
Tykhe Corp [HALB] is a Pink Sheet which is traded through a dealer network over-the-counter (OTC). The company currently falls under 'Nano-Cap' category with a current market capitalization of 1.82 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Tykhe Corp's market, we take the total number of its shares issued and multiply it by Tykhe Corp's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Tykhe Corp conducts business under Healthcare sector and is part of Biotechnology industry. Tykhe Corp currently holds about 8.16 K in cash with (785.3 K) of positive cash flow from operations.
Check Tykhe Corp Probability Of Bankruptcy

Tykhe Corp Risk Profiles

Tykhe Stock Against Markets

Be your own money manager

Our tools can tell you how much better you can do entering a position in Tykhe Corp without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Positions Ratings Now

   

Positions Ratings

Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
All  Next Launch Module

Tykhe Corp Corporate Management

Heidi CarlDirector DirectorProfile
Mitchell MDCTO BoardProfile
William HartmanCEO PresProfile
MD FAANChief BoardProfile
AVS MBACOO DirectorProfile

Other Information on Investing in Tykhe Pink Sheet

Tykhe Corp financial ratios help investors to determine whether Tykhe Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Tykhe with respect to the benefits of owning Tykhe Corp security.